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spectroscopyWild-type phospholamban (WT-PLB), a Ca2+-ATPase (SERCA) regulator in the sarcoplasmic reticulummem-
brane, was studied using TOAC nitroxide spin labeling, magnetically aligned bicelles, and electron paramag-
netic resonance (EPR) spectroscopy to ascertain structural and dynamic information. Different structural
domains of PLB (transmembrane segment: positions 42 and 45, loop region: position 20, and cytoplasmic do-
main: position 10) were probed with rigid TOAC spin labels to extract the transmembrane helical tilt and
structural dynamic information, which is crucial for understanding the regulatory function of PLB in modu-
lating Ca2+-ATPase activity. Aligned experiments indicate that the transmembrane domain of wild-type
PLB has a helical tilt of 13°±4° in DMPC/DHPC bicelles. TOAC spin labels placed on the WT-PLB transmem-
brane domain showed highly restricted motion with more than 100 ns rotational correlation time (τc);
whereas the loop, and the cytoplasmic regions each consists of two distinct motional dynamics: one fast com-
ponent in the sub-nanosecond scale and the other component is slower dynamics in the nanosecond range.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Phospholamban (PLB) is a 52-residue homopentameric trans-
membrane protein that regulates the cardiac sarco/endoplasmic re-
ticulum calcium ATPase (SERCA) activity [1,2]. SERCA is responsible
for translocation of calcium ions across the lumen in the sarcoplasmic
reticulum (SR) membrane; therefore, controlling the contraction and
relaxation cycle of the heart [3,4]. In its unphosphorylated form, PLB
interacts with SERCA with apparent afﬁnity for Ca2+ ions; whereas
phosphorylation of PLB at Ser-16 and Thr-17 by cyclic AMP- and
Ca2+/calmodulin dependent kinases relieves the PLB–SERCA inhibi-
tion [3,5].
In lipid bilayers, PLB exists mainly in a pentameric form. PLB has 3
main structural features: (i) cytoplasmic region: (residues: 1–16, do-
main Ia), (ii) hinge region: (residues 17–30, domain Ib), and
(iii) transmembrane (TM) section (residues 31–52, domain II). Earlier
studies of PLB disagree whether the pentameric protein consists of a
continuous helix or two helices connected by an unstructured loop
or β-sheet region [6,7]. Two models of PLB have been proposed byo/endoplasmic reticulum Ca2+-
line; DHPC, 1,2-Dihexanoyl-sn-
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rights reserved.the Thomas/Veglia groups (pinwheel model) [8,9] and the Chou
group (bellﬂower like structural model) [10]. The pinwheel model in-
dicates that the cytoplasmic region of PLB lies on and interacts with
the membrane surface, which was also supported by reports from
the Middleton and Lorigan groups [11,12]. However, the bellﬂower
like model, suggests that the cytoplasmic region of the PLB points
away from the membrane surface making a bellﬂower-like structure.
In addition, solution and solid-state NMR studies have also been per-
formed on AFA-PLB (fully functional PLB monomer with C36A, C41F,
C46A mutations) [13,14]. The Veglia/Thomas group proposed that
the cytosolic segment of AFA-PLB is α-helical and interacts with the
membrane surface and is connected to the transmembrane domain
through the loop region [13]. Conversely, the Baldus group reports
that the cytosolic region of AFA-PLB is completely unstructured and
has minimal interaction with the membrane surface [14]. Thus,
there is a debate about both the structure and orientation of the cyto-
plasmic segment of PLB. Even those models, which agree on the
α-helical secondary structure of the PLB cytoplasmic domain, dis-
agree on its orientation with respect to the membrane and have
reported inconsistent helical tilt angles varying from 20° in bellﬂower
like model [10], to 28° in continuous helix model [6], and 50°–60° in
an extended helix-sheet-helix model [7], and ~90° in the pinwheel
model [9]. Although all proposed PLB models agree on the α-helical
secondary structure of the transmembrane domain, there are also in-
consistent reports in the literature about the helical tilt of the
transmembrane domain of PLB [6,9,15–17]. The helical tilt of the
transmembrane domain of PLB varies from 28° to 10°. The purpose
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angles using newly developed aligned EPR spectroscopic techniques.
The TOAC spin label was used as a probe for EPR measurements
because it is a compact probe that is rigidly coupled to the α-carbon
and reports more accurately on the position, orientation and back-
bone dynamics of PLB [18]. SDS-PAGE on TOAC labeled wild-type
PLB indicated that this spin label does not signiﬁcantly alter the
pentamer to monomer distribution of wild-type PLB. This is also
consistent with a previous study [9]. Previously reported gels suggest
point mutations from wild-type PLB to N27A do not signiﬁcantly alter
the pentamer to monomer distribution [19]. Additional biophysical
techniques are needed to verify pertinent membrane protein struc-
tural information. The second aspect of the project is to compare
the dynamics of PLB in different regions (e.g., transmembrane, loop,
and cytoplasmic domain) with EPR spectroscopy.2. Materials and method
2.1. Peptide synthesis
Solid phase peptide synthesis was carried out on a 433A peptide
synthesizer (Applied Biosystems Inc., Foster City, CA) using Fmoc-
protection chemistry. Amino acid sequences of the phospholamban
protein are shown in Fig. 1.
A UV-detector (301 nm wavelength) on the 433A peptide synthe-
sizer was used for monitoring the Fmoc-group removal from the N-
terminus of the growing peptide. A modiﬁed version of 0.1 mmol
Fmoc chemistry protocol (SynthAssist 2.0 software, Applied Biosys-
tems) was used for peptide synthesis. The software modiﬁcation
facilitated optimal peptide synthesis by enabling special functions
such as extended double coupling, unnatural amino acid incorpora-
tion, and increased reaction times. All amino acids used were in
both Fmoc protected and side-chains protected form to minimize un-
necessary side chain reactions during peptide synthesis. Solid phase
peptide synthesis was used for site-speciﬁc TOAC labeling in PLB by
functionalizing the amino terminal of the TOAC with the Fmoc
group [20]. The synthesis of Fmoc-TOAC was carried out following
standard procedures from the literature [20]. The synthesis and puri-
ﬁcation of the full-length PLB provided challenges because of its long
amino acid sequence and highly hydrophobic nature. In many cases,
TOAC spin-labeling led to peptide truncations. These truncated
peptides had similar hydrophobicity, to the full-length peptide,
which complicates protein puriﬁcation and makes the reverse phase
HPLC extremely difﬁcult. Therefore, an optimized full-length PLB syn-
thesis took about 10 days for completion. The TOAC labeled PLB was
synthesized following standard protocols published in the literature
[21–23]. When only HBTU/HOBt coupling agents were used, many
truncations that resulted made it difﬁcult to get the full-lengthFig. 1. Amino acid sequences of PLB (A) WT-PLB, (B) TOAC-10 PLB,TOAC labeled PLB synthesized. The protein synthesis was optimized
(i) using a pseudoproline dipeptide Fmoc-Leu-Thr (ψMe,Me-Pro)-OH
from Novabiochem, San Diego, CA [24] and (ii) using a superior cou-
pling agent HATU/HOAt [25] to attach the TOAC spin label as well as a
few amino acids surrounding it (two amino acids preceding the TOAC
and 5–6 amino acids after the TOAC attachment) with extended
coupling times. This method ensured the efﬁcient coupling of the
TOAC spin probe and also prevented peptide truncation just after
the TOAC attachment caused due to low nucleophilicity of the TOAC
amino group [21,26]. The rest of the amino acids were attached
using the normal HBTU/HOBt coupling reagent.
About 150 mg of peptide resin was treated with a cleavage mix-
ture (85% TFA, 5% TIS, 5% anisole and 5% distilled water) for 3 h and
45 min. The protein–resin mixture was ﬁltered; resins were rinsed
with TFA. The ﬁltrate was concentrated and precipitated in ice-cold
methyl tert-butyl ether. The proteins were collected by centrifugation
and vacuum dried overnight. The crude proteins were puriﬁed on an
Amersham Pharmacia Biotech AKTA Explorer 10S HPLC system using
reversed phase polymer column (Vydac cat. # 259VHP82215, 8 μm,
22 mm×150 mm). The HPLC solvent system for PLB puriﬁcation
comprised of H2O with 0.1% TFA (Solvent A) and a mixture of 57% iso-
propyl alcohol (IPA), 38% acetonitrile (MeCN), and 5% water with 0.1%
TFA (Solvent B). All TOAC-labeled PLBs were double puriﬁed with a
slightly modiﬁed solvent system in reversed phase C-18 semiprep col-
umn (Vydac cat. # 218TP1010, 10 μm, 10 mm×250 mm) to ensure the
high purity needed for EPR spectroscopy (~95%). The solutions from
the corresponding HPLC peaks were lyophilized to yield pure protein.
The HPLC puriﬁed proteins were treated with a few drops of 10% aq.
ammonia (3.5 h, pH=9.5) in a 80:20 n-propanol–water mixture to
fully retain the radical character of the TOAC nitroxide. This step was
necessary since TFA converts nitroxide label into a hydroxylamine
form during peptide cleavage and puriﬁcation process, and the
radical character of TOAC is partially lost. The purity of the peptide
was conﬁrmed to be ~95% by analytical high performance liquid
chromatography (HPLC).2.2. Sample preparation
The PLB bicelle samples were prepared from DMPC, DHPC,
PEG200-PE, cholesterol and spin-labeled peptide in the molar ratio
of 3.5/1/0.035/0.35/0.0035 respectively. The peptide–lipid mixture
(250 lipids/PLB) was taken in a pear-shaped ﬂask and dried with ni-
trogen gas and then desiccated overnight using a high-vacuum
pump to remove the residual solvents. The next day, 150 μL of the
HEPES buffer (100 mM, pH=7.0) was added to the lipid peptide mix-
ture to make 25% lipids sample (w/w). The mixture was periodically
vortexed and chilled in an ice bath until all of the lipids were
completely dissolved. Extreme care was taken in this step to make(C) TOAC-20 PLB, (D) TOAC-42 PLB, and (E) TOAC-45 WT-PLB.
Fig. 2. CW-EPR spectra of TOAC-42 PLB [(A), (B), (C)], and TOAC-45 PLB [(D), (E), (F)]
in DMPC/DHPC bicelles at 318 K. (A) and (D) represent parallel aligned (n||Bo) spectra,
(B) and (E) represent perpendicular aligned (n⊥Bo) spectra, and (C) and (F) represent
randomly dispersed spectra. The black traces represent experimental EPR spectra, and
red traces are the corresponding ﬁts from NLSL simulations.
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bicelle samples were sonicated (30 min, Fisher Scientiﬁc FS30, Flor-
ence, KY) and subjected to four freeze thaw cycles to remove air bub-
bles and further homogenize the sample. The magnetic alignment of
bicelles was achieved by adding 20 mol% of speciﬁc lanthanide ions
(either Dy3+ or Tm3+) into the DMPC/DHPC bicelles [22,27]. About
50 μL of sample were drawn into capillary tubes, sealed with cristo-
seal at the end and placed into a quartz tube (Wilmad, 707-SQ-
250 M) for EPR spectroscopy.
2.3. EPR spectroscopy
EPR experiments were performed on a Bruker EMX X-band CW-
EPR spectrometer operating at a microwave frequency of 9.5 GHz,
10 mW microwave power, 100 kHz modulation frequency, and
1.0 kHz modulation amplitude. All EPR spectra were recorded at
318 K to achieve optimum alignment. A 42-s ﬁeld sweep scan with
a central ﬁeld of 3400 G and sweep-width of 100 G were applied.
2.4. EPR spectral simulations
The EPR spectra were rigorously analyzed using the nonlinear
least-squares (NLSL) analysis program [28,29]. The EPR spectrum of
TOAC-10 PLB, and the randomly dispersed spectra of TOAC-20,
TOAC-42 and TOAC-45 PLB were analyzed using the MOMD (macro-
scopic order, microscopic disorder) model incorporated into the
NLSL program. The parallel and perpendicular aligned samples were
simulated using NLSL simulations with the introduction of the direc-
tor tilt angle (Ψ). We assumed that the restoring potential is symmet-
ric to the bilayer normal so that only the c20 axial symmetry term
determines the order parameters. The diffusion tilt angle (βd=21°)
was taken from the solution structure of PLB and ﬁxed during simula-
tions. The truncated basis sets: Lemax=16, Lomax=15, Kmax=10, and
Mmax=10 were used along with the nuclear spin transition index
values p1=2 for the 42-TOAC and 45-TOAC transmembrane spectral
simulations. For the cytoplasmic and loop region spectra simulations,
these parameters were taken [12, 11, 8, 8, 2] for the T-component and
[4, 3, 2, 2, 2] for the R-component, similar to Nesmelov et al. [30]. Dur-
ing simulations, A, g, linewidths and the dynamic parameters were
tightly reﬁned using the starting set of hyperﬁne and g-tensoral pa-
rameters from the literature [30]. Each randomly dispersed spectrum
was simulated with 40 different orientations (described by the pa-
rameter nort in the MOMD simulation) to get full convergence. The
rotational correlation time is deﬁned in terms of rotational diffusion
coefﬁcients DR, as τc=1/6DR. For anisotropic motions, the correlation
time for unrestricted axial rotation is given by τc(||)=1/6DR(||) and re-
stricted wobbling motions as τc(⊥)=1/6DR(⊥) with an associated
order parameter S as described by Nesmelov et al. [30].
3. Results and discussion
Fig. 2 shows CW-EPR spectra of two PLB transmembrane sites la-
beled with TOAC at positions 42 (left panel) and 45 (right panel)
reconstituted into DMPC/DHPC lipid bicelles at 318 K. The black
traces represent experimental EPR spectra and the red traces repre-
sent the corresponding best ﬁts from the NLSL simulations. The EPR
simulation parameters are given in Table S1. Fig. 2(A) and (D) repre-
sents Tm3+-doped parallel-aligned spectra and Fig. 2(B) and
(E) shows Dy3+-doped perpendicular aligned spectra. The parallel
and perpendicular alignments are described in the terms of the orien-
tation of the molecular Z-axis of the TOAC spin label (or Z-axis of stat-
ic magnetic ﬁeld) with respect to the bilayer normal. Fig. 2(C) and
(F) shows a broad unaligned spectrum corresponding to the rigid
limit spectra of the TOAC spin label at positions 42 and 45.
Orientation-dependent alignment of the TOAC spin probe in the PLBdata is clearly visible in the EPR spectra of aligned DMPC/DHPC lipid
bicelles, when compared to the unoriented spectra.
In parallel-aligned bicelles, the membrane normal as well as the z-
axis of the TOAC nitroxide are nearly parallel to the static magnetic
ﬁeld giving rise to a maximum hyperﬁne splitting value of 27.2 G
and 26.9 G for TOAC-42 and TOAC-45 respectively. For the perpendic-
ular alignment (n⊥Bo), the z-axis of the TOAC nitroxide orients near-
ly perpendicular to the magnetic ﬁeld thereby averaging the x- and y-
nitroxide hyperﬁne tensors yielding an EPR spectrum with a minimal
hyperﬁne splitting (11.2 G for TOAC-42 and 11.4 G for TOAC-45).
3.1. Transmembrane helical tilt calculation for WT-PLB
The aligned EPR spectra in Fig. 2 can be used to calculate the heli-
cal tilt angle of the transmembrane domain of WT-PLB using estab-
lished procedures in the literature [22,31,32]. The details about the
matrix algebra required to calculate the angle between the long heli-
cal axis vector (h) and the bilayer normal (n), angle ϕ from the exper-
imentally determined director tilt vector (ZD) and the bilayer normal
(angle ξ) of a parallel aligned bicelle sample can be found in Inbaraj et
al. [22]. Brieﬂy, Eq. (1) can be used to calculate the director tilt angle
when the magnetic ﬁeld (Bo) makes an angle (ψ) with the director tilt
vector (ZD), the axis of motional averaging.
Aexp ¼ A2jj cos2ψþ A2⊥ sin2ψ
h i1
2 ð1Þ
cosψ ¼ ZD⋅n
ZDj j⋅ nj j
ð2Þ
which ﬁnally reduces to,
cos ψ ¼ sin βnð Þ⋅ cos αnð Þ⋅ sin βDð Þ⋅ cos αDð Þ
þ sin βnð Þ⋅ sin αnð Þ⋅ sin βDð Þ⋅ sin αDð Þ þ cos βnð Þ⋅ cos βDð Þ;
ð3Þ
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The hyperﬁne splitting values measured from the aligned PLB
spectra at 42-position, were Aexp=27.2 G for parallel aligned
spectrum (Fig. 2(A)), and Aexp=11.2 G for perpendicularly aligned
spectrum (Fig. 2(B)). A||=29.8 G and A⊥=7.5 G were obtained
from the randomly dispersed spectrum [Fig. 2(C)]. Using Eq. (1), the
director tilt angle (ψ), was calculated as 25°±4° which agrees well
with the 27°±4° director tilt angle obtained from the best-ﬁt NLSL
simulations. Using the 25° director tilt angle, the 21° tilt of ZD with re-
spect to the helical axis based upon crystal structure, and unitary
transformations involving three Euler angles (α, β, γ), a helix tilt
angle of 11°±4° was calculated. This value agrees well with a helical
tilt of 14°±4° calculated by using the director tilt angle of 27° directly
obtained from the NLSL simulations.
Similarly, the hyperﬁne splitting values measured from aligned
TOAC-45 PLB spectra were Aexp=26.9 G for the parallel aligned spec-
trum (Fig. 2(D)), and Aexp=11.37 G for the perpendicularly aligned
spectrum (Fig. 2(E)). A||=29.68 G and A⊥=7.65 G values were
obtained directly from the randomly dispersed spectrum (Fig. 2(F)).
Using Eq. (1), the director tilt angle (ψ), was calculated to be
26°±4° which agreed well with the director tilt angle of 28°±4°
obtained from the best-ﬁt NLSL simulations. The helix tilt angle of
12°±4° was calculated using the 26° director tilt from aligned spec-
tra [Fig. 2(D), (E), and (F)]. Similarly, the 15°±4° helical tilt angle
was obtained using a 28° director tilt from the NLSL simulations.
By orienting TOAC-labeled PLB reconstituted in DMPC/DHPC
bicelles and applying the method used in Inbaraj et al., the transmem-
brane helical tilt of WT-PLB was calculated to be 13°±4° (average of
four tilt angles for two residues). This helical tilt angle agrees well
with the tilt angles reported in previous literature [9,16,33]. Torres
et al. reported the helix tilt of 10°±6° for TM-PLB in a hydrated
lipid bilayer using ATR-FTIR (Attenuated Total Reﬂection Fourier
Transform Infrared) site-directed dichroism and the restraints
obtained from molecular dynamics simulation [33]. Karp et al. per-
formed 13C-CPMAS (cross-polarization magic angle spinning), 2H,
and REDOR (Rotational-Echo Double Resonance) solid-state NMR
studies on TM-PLB and calculated a helical tilt angle of 11°±5° [16].
A very important study by Traaseth et al. used 1H/15N PISEMA (Polar-
ization Inversion Spin Exchange at the Magic Angle) solid-state NMR
experiments on WT-PLB in oriented lipid bilayer and calculated a
15°±5° helix tilt angle with respect to the bilayer normal [9]. Thus,
utilizing the rigidly bound TOAC spin label and the magnetic align-
ment techniques the helical tilt of the membrane bound protein can
easily be calculated. It is important to verify the structural parameters
such as helical tilt with more than one biophysical technique. The
helical tilt information can only be ascertained using the aligned tech-
niques discussed in this paper.
3.2. Backbone dynamics of the transmembrane domain of PLB
The rigidly attached TOAC spin label on the PLB transmembrane
segment not only enables us to calculate the helical tilt angle, but
also provides direct insight into the protein backbone dynamics
[18,22,34]. The EPR spectra of randomly dispersed WT-PLB at posi-
tions 42 and 45 (Fig. 2(C) and (F)) produced broadened EPR line-
shapes indicating slow motion on the EPR timescale. Simulations of
the TOAC EPR spectra using the MOMD method within the NLSL pro-
gram [28] (see Table S1 for EPR simulation parameters) resulted in a
single component ﬁt with very long rotational correlation times. The
results show slow uniaxial rotation around the helix axis parallel to
the bilayer normal indicated by the τc(||) value (τc(||)=296 ns for
TOAC-45 PLB and τc(||)=310 ns for TOAC-42 PLB). However, the wob-
bling motion of the TOAC nitroxide perpendicular to the long helix-
axis is quite fast [τc(⊥)=3 ns for TOAC-45 PLB and τc(⊥)=8 ns for
TOAC-42 PLB]. The molecular order parameters for TOAC-45 PLBand TOAC-42 PLB calculated from the NLSL simulations were 0.84±
0.02 and 0.87±0.02 respectively, which indicate a restricted motion
of the TOAC nitroxides even at a high temperature of 318 K in the
membrane.
Nesmelov et al. have reported the slow rotational motion around
the transmembrane helix of PLB monomer [τc(||)=105 ns] for
TOAC-46 AFA-PLB and fast wobbling motion of TOAC nitroxide per-
pendicular to the helical axis [τc(⊥)=2 ns] with a 0.93 order parame-
ter value [30]. Our simulation results are similar to Nesmelov et al.
given the fact that wild-type PLB has slower dynamics than its mono-
meric counterpart. Abu-Baker et al. have shown a broad and well-
deﬁned powder pattern spectrum for 15N-labeled WT-PLB at position
42 in POPC multilamellar vesicles with a corresponding chemical shift
anisotropy (CSA) value of 172.8 ppm [35]. This also indicates that the
backbone motion of transmembrane section of WT-PLB is quite im-
mobile on the NMR timescale.
3.3. Conformational dynamics of the cytoplasmic domain of PLB
To study the conformational dynamics of the cytoplasmic domain
of PLB, SDSL was conducted at Ser-10 with TOAC spin label. The TOAC
labeled PLB was reconstituted into DMPC/DHPC bicelles, and the EPR
spectrum was recorded at 318 K. The TOAC-10 PLB spectrum (Fig. 3)
clearly shows two motional components similar to the EPR spectrum
of TOAC-11 AFA PLB (fully functional PLB monomer with C36A, C41F,
and C46A mutations and TOAC labeling at position Ala-11) [13,18,30].
The EPR spectrum in Fig. 3 was ﬁt best by two-component MOMD
simulations with distinct rotational correlation times: τc(T)=7 ns, for
the ordered T-state, and τc(R)=0.56 ns, for the dynamically disor-
dered R-state. The two-componentmodel gave a better ﬁt than a single
component, but a three-component ﬁt did not improve the ﬁt. The
order parameter was determined to be 0.62±0.04. The EPR simulation
parameters are given in Table S1. The T- and R-components in the EPR
spectrum correspond to the two distinct conformational states of the
PLB cytoplasmic domain [36]. The T conformer is stabilized through a
charged interaction with the membrane surface, whereas the R-
conformer points away from the surface and is positioned favorably
to interact with its regulatory target SERCA [13,30]. The T and R compo-
nents in the EPR spectrum were calculated to be ~85% for the ordered
T-component and ~15% for the more dynamic R-component, which is
similar to the report of Nesmelov et al. [30].
Nesmelov and co-workers [30] have reported the rotational correla-
tion times of 3.5±0.3 ns and 0.68±0.02 ns for the T and R conformers
of the PLB monomer with a mole fraction of 0.84 and 0.16 for T and R
conformations respectively. In this paper, our results on the dynamics
of the PLB pentamer are 7.0±0.4 ns for the T conformation and
0.56±0.03 ns for the R conformation. The mole fraction of T (0.85±
0.02) and R (0.15±0.02) conformations indicate that the pentameric
PLB prefers to stay predominantly in the T-conformation similar to
the Pinwheel model proposed by Thomas/Veglia groups [8,9] and sup-
ported by the Lorigan [12] and Middleton groups [11]. Veglia and
co-workers have also shown almost identical resonance positions of
WT-PLB and AFA-PLB in their published (1H/15N]-TROSY-HSQC spec-
trum for residues 2–31 [9]. The close match between our rotational cor-
relation time for the T and R components and their relative proportion
indicates that WT-PLB and AFA-PLB have similar dynamic features in
the cytoplasmic domain. Topology mapping studies on the PLB
cytoplasmic domain showed that Ser-10 was the most solvent exposed
residue, as its TROSY-HSQC spectrum was most effectively quenched
by adding Gd3+ ions [9]. However, the Ser-10 residue also retained
~80% of the intensity with 5-doxyl steric acid; another paramagnetic
agent that effectively relaxes the hydrophobic residues just below the
phosphate head group in the membrane [9]. This indicates that Ser-
10 also interacts with the membrane surface, which is consistent
with our two-component spectrum of TOAC-10 PLB. Using both uni-
formly 15N-labeled WT-PLB and site-speciﬁcally 15N-labeled PLB (at
Fig. 3. CW-EPR spectra of TOAC-10 PLB in DMPC/DHPC bicelles at 318 K. The black
traces represent experimental EPR spectra and red traces are the ﬁts from MOMD
simulations.
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distinct 15N-amide backbone dynamics; a relatively narrow isotropic
component corresponding to themobile cytoplasmic backbone compo-
nent and a broad well-deﬁned powder-like component corresponding
to the rigid component [35].
Magnetic alignment studies were also performed on TOAC-10 PLB.
However, due to a high backbone dynamics of the cytoplasmic do-
main and its conformational heterogeneity, we could not obtain
well-aligned EPR spectra. The EPR spectra were highly isotropic in na-
ture (data not shown) due to the fast motional averaging of the spin
probe on the EPR timescale.3.4. Loop region conformational dynamics of PLB
The 20Met→TOAC mutation was made to study the loop region
dynamics of PLB. Fig. 4 shows the randomly dispersed spectrum at
318 K, which reveals two motional components in the EPR spectrum;
a fast motional component (R) represented by a sharp peak and a less
dynamic component (T) represented by the broad peak. The two-
component MOMD ﬁt (see Table S1 for EPR simulation parameters)
to the experimental spectrum shows that the rotational correlation
time of the less dynamic T-component is (3.0±0.4) ns and the dy-
namically disordered R-component is (2.0±0.3) ns. The spectral
analysis yielded the distribution of T and R components as ~69%
and ~31%, respectively.Fig. 4. CW-EPR spectra of 20-TOAC PLB in DMPC/DHPC bicelles at 318 K. The black trace
represents experimental EPR spectra and red trace is the ﬁt from MOMD simulations.4. Conclusions
Rigid TOAC spin labeling and aligned EPR spectroscopic tech-
niques were used to probe the transmembrane helical tilt and
dynamics of the wild-type phospholamban. This study reveals that
the motional dynamics of transmembrane domain is highly restricted
with a rotational correlation time more than 100 ns. Both the loop
and the cytoplasmic domain of WT-PLB possess two backbone
motions corresponding to the R- and T-conformational states similar
to AFA-PLB. The T-component had a few nanosecond rotational corre-
lation times as opposed to a sub-nanosecond rotational correlation
time for the dynamically disordered R-component. The major T com-
ponent corresponds to the cytoplasmic domain of PLB interacting
with the membrane surface, while the minor R component (smaller
population) is moving faster and does not interact with the mem-
brane. The data agrees with the NMR/EPR pinwheel model discussed
in the literature by the Minnesota researchers [37]. Recent work by
the Veglia group suggests that the T state is the non-active ground
state [36], while the R state is the loss of function state [37]. The func-
tion of SERCA can be controlled by enhancing the R state via proper
design of mutants [37]. In addition, they report a helical tilt of 13°
using solid-state NMR spectroscopy which agrees very well with the
reported helical tilt of 13°±4° for the transmembrane domain calcu-
lated using NLSL and aligned EPR spectroscopic techniques. WT-PLB
pre-exists in multiple conformations and equilibrated in its two
major T and R conformational states when reconstituted in different
lipid membrane environments [37]. By ﬁne tuning the PLB conforma-
tional equilibria, lipid membrane can be represented as a third
element for allosteric control of SERCA [38].
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbamem.2011.11.030.
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